{
    "organizations": [],
    "uuid": "2c31125c949c3063be33fe6ea4d774cf38add553",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shenzhen-kangtai-biological-produc/brief-shenzhen-kangtai-biological-products-gets-clinical-trial-approval-for-its-injection-idUSL4N1PI2EG",
    "ord_in_thread": 0,
    "title": "BRIEF-Shenzhen Kangtai Biological Products gets clinical trial approval for its injection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 23 (Reuters) - Shenzhen Kangtai Biological Products Co Ltd\n* Says it and wholly owned biotechnology unit get clinical trial approval for its injection, which will be used for treatment of hand-foot-and-mouth disease\nSource text in Chinese: goo.gl/73rxD5\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-23T13:12:00.000+02:00",
    "crawled": "2018-01-24T15:53:01.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shenzhen",
        "kangtai",
        "biological",
        "product",
        "co",
        "ltd",
        "say",
        "wholly",
        "owned",
        "biotechnology",
        "unit",
        "get",
        "clinical",
        "trial",
        "approval",
        "injection",
        "used",
        "treatment",
        "disease",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}